Aclaris Therapeutics Inc (NASDAQ:ACRS)

13.83
Delayed Data
As of Jul 01
 -0.13 / -0.93%
Today’s Change
9.26
Today|||52-Week Range
19.97
-4.88%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Aclaris Therapeutics Inc have a median target of 30.00, with a high estimate of 50.00 and a low estimate of 26.00. The median estimate represents a +116.92% increase from the last price of 13.83.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Aclaris Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.36
Sales
$1.6M
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -15.59%
 
 
 
 
 
 
Growthannually 7.08%
 
 
 
 
 
 

Sales

Growthquarterly 10.93%
 
 
 
 
 
 
Growthannually -4.84%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.